U.S. Markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Silver

    22.42
    -0.33 (-1.44%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.3402%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • Vix

    20.81
    +2.12 (+11.34%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.4286%)
     
  • USD/JPY

    109.8950
    +0.1770 (+0.1613%)
     
  • BTC-USD

    48,415.10
    +1,046.18 (+2.21%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

Is Patterson Companies (PDCO) Outperforming Other Medical Stocks This Year?

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Investors focused on the Medical space have likely heard of Patterson Companies (PDCO), but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

Patterson Companies is a member of our Medical group, which includes 927 different companies and currently sits at #12 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. PDCO is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for PDCO's full-year earnings has moved 14.44% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Based on the latest available data, PDCO has gained about 34.47% so far this year. Meanwhile, the Medical sector has returned an average of 1.17% on a year-to-date basis. This means that Patterson Companies is outperforming the sector as a whole this year.

Looking more specifically, PDCO belongs to the Medical - Dental Supplies industry, which includes 22 individual stocks and currently sits at #53 in the Zacks Industry Rank. On average, this group has gained an average of 11.53% so far this year, meaning that PDCO is performing better in terms of year-to-date returns.

Investors with an interest in Medical stocks should continue to track PDCO. The stock will be looking to continue its solid performance.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Patterson Companies, Inc. (PDCO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research